The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
Open accessAbstract
Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic and non-hematopoietic cells, including monocytes, macrophages, keratinocytes and mesenchymal cell. IL-18 could potentially induce inflammatory and cytotoxic immune cell activities leading to autoimmunity. Its elevated levels have been reported in the blood of patients with some immune-related diseases, including rheumatoid arthritis, systemic lupus erythematosus, type I diabetes mellitus, atopic dermatitis, psoriasis, and inflammatory bowel disease. In the present review, we aimed to summarize the biological properties of IL-18 and its pathological role in different autoimmune diseases. We also reported some monoclonal antibodies and drugs targeting IL-18. Most of these monoclonal antibodies and drugs have only produced partial effectiveness or complete ineffectiveness in vitro,in vivo and human studies. The ineffectiveness of these drugs targeting IL-18 may be largely due to the loophole caused by the involvement of other cytokines and proteins in the signaling pathway of many inflammatory diseases besides the involvement of IL-18. Combination drug therapies, that focus on IL-18 inhibition, in addition to other cytokines, are highly recommended to be considered as an important area of research that needs to be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Yang, Y., Li, G., & Zhang, R. (2022) · BioMed Research International · doi:10.1155/2022/5984184 · Cited by 7
RetractedZhao, N., & Dong, C. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/3555982 · Cited by 3
RetractedContinuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Preliminary criteria for classification of adult Still's disease.
Yamaguchi, M., Ohta, A., Tsunematsu, T., Kasukawa, R., Mizushima, Y., Kashiwagi, H., Kashiwazaki, S., Tanimoto, K., Matsumoto, Y., & Ota, T. (1992) · PubMed · Cited by 1,788
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90490-5 · Cited by 1,417
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,315
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,155
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
Pyroptotic cell death defends against intracellular pathogens
Jorgensen, I., & Miao, E. A. (2015) · Immunological Reviews · doi:10.1111/imr.12287 · Cited by 1,021
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80543-9 · Cited by 911
Rodrigues, T. S., de Sá, K. S. G., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201707 · Cited by 839
Cytokine-induced memory-like natural killer cells
Cooper, M. A., Elliott, J. M., Keyel, P. A., Yang, L., Carrero, J. A., & Yokoyama, W. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813192106 · Cited by 831
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
NAKANISHI, K., YOSHIMOTO, T., TSUTSUI, H., & OKAMURA, H. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00015-0 · Cited by 662
Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4274 · Cited by 624
The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress
O'Neill, L. A. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00701.x · Cited by 616
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2018) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 606
Munder, M., Mallo, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2103 · Cited by 600
Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.207 · Cited by 588
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 572
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 563
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M. R., Palm, N. W., Bailis, W., Low, J. S., Harman, C. C. D., Graham, M., Elinav, E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.072 · Cited by 558
PI3K-mediated negative feedback regulation of IL-12 production in DCs
Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., & Koyasu, S. (2002) · Nature Immunology · doi:10.1038/ni825 · Cited by 529
Gerfaud-Valentin, M., Jamilloux, Y., Iwaz, J., & Sève, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.058 · Cited by 518
An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
Rabinovitch, A. (1998) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199806)14:2<129::aid-dmr208>3.0.co;2-v · Cited by 461
Nold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3103 · Cited by 439
Kaplon, H., & Reichert, J. M. (2019) · mAbs · doi:10.1080/19420862.2018.1556465 · Cited by 434
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
Siegmund, B., Lehr, H.-A., Fantuzzi, G., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231473998 · Cited by 421
Yoshimoto, T., Okamura, H., Tagawa, Y.-I., Iwakura, Y., & Nakanishi, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3948 · Cited by 381
Cutting Edge: Priming of NK Cells by IL-18
Chaix, J., Tessmer, M. S., Hoebe, K., Fuséri, N., Ryffel, B., Dalod, M., Alexopoulou, L., Beutler, B., Brossay, L., Vivier, E., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1627 · Cited by 374
Overview of interleukin-18: more than an interferon-γ inducing factor
Dinarello, C. A., Novick, D., Puren, A. J., Fantuzzi, G., Shapiro, L., Mühl, H., Yoon, D.-Y., Reznikov, L. L., Kim, S.-H., & Rubinstein, M. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.658 · Cited by 374
Dinarello, C. A. (1999) · Methods · doi:10.1006/meth.1999.0837 · Cited by 369
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Zhou, T., Damsky, W., Weizman, O.-E., McGeary, M. K., Hartmann, K. P., Rosen, C. E., Fischer, S., Jackson, R., Flavell, R. A., Wang, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2422-6 · Cited by 363
IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6
Yoshimoto, T., Mizutani, H., Tsutsui, H., Noben-Trauth, N., Yamanaka, K.-I., Tanaka, M., Izumi, S., Okamura, H., Paul, W. E., & Nakanishi, K. (2000) · Nature Immunology · doi:10.1038/77811 · Cited by 352
Hoshino, T., Wiltrout, R. H., & Young, H. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5070 · Cited by 349
Kim, S.-H., Eisenstein, M., Reznikov, L., Fantuzzi, G., Novick, D., Rubinstein, M., & Dinarello, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1190 · Cited by 341
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
Fautrel, B., Moel, G. L., Saint-Marcoux, B., Taupin, P., Vignes, S., Rozenberg, S., Koeger, A. C., Meyer, O., Guillevin, L., Pietté, J. C., et al. (2001) · PubMed · Cited by 316
Sugawara, S., Uehara, A., Nochi, T., Yamaguchi, T., Ueda, H., Sugiyama, A., Hanzawa, K., Kumagai, K., Okamura, H., & Takada, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6568 · Cited by 297
IMGT, the International ImMunoGeneTics Information System
Lefranc, M.-P. (2011) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top115 · Cited by 292
Bossaller, L., Chiang, P.-I., Schmidt-Lauber, C., Ganesan, S., Kaiser, W. J., Rathinam, V. A. K., Mocarski, E. S., Subramanian, D., Green, D. R., Silverman, N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202121 · Cited by 290
Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H.-A., Hartmann, G., Dinarello, C. A., Endres, S., & Eigler, A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.4.r1264 · Cited by 288
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
Hoshino, K., Tsutsui, H., Kawai, T., Takeda, K., Nakanishi, K., Takeda, Y., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5041 · Cited by 277
Sivakumar, P. V., Westrich, G. M., Kanaly, S., Garka, K., Born, T. L., Derry, J. M. J., & Viney, J. L. (2002) · Gut · doi:10.1136/gut.50.6.812 · Cited by 267
Ruiz-Irastorza, G., Khamashta, M. A., Castellino, G., & Hughes, G. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04239-2 · Cited by 257
Unique Action of Interleukin-18 on T Cells and Other Immune Cells
Nakanishi, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00763 · Cited by 256
Interleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K., Kashiwamura, S.-I., Hada, T., Akira, S., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80111-9 · Cited by 243
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M. A., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A. J., Graber, P., Aloni, S., Cirillo, R., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12097 · Cited by 240
Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18
Wei, X.-Q., Leung, B. P., Arthur, H. M. L., McInnes, I. B., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.517 · Cited by 207
Matsui, K., Yoshimoto, T., Tsutsui, H., Hyodo, Y., Hayashi, N., Hiroishi, K., Kawada, N., Okamura, H., Nakanishi, K., & Higashino, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.97 · Cited by 205
The genetic and immunopathological processes underlying collagen‐induced arthritis
Luross, J. A., & Williams, N. A. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01267.x · Cited by 199
Pathophysiological roles of interleukin-18 in inflammatory liver diseases
Tsutsui, H., Matsui, K., Okamura, H., & Nakanishi, K. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017418.x · Cited by 198
Natural killer cells determine the outcome of B cell–mediated autoimmunity
Shi, F.-D., Wang, H.-B., Li, H., Hong, S., Taniguchi, M., Link, H., Kaer, L. V., & Ljunggren, H.-G. (2000) · Nature Immunology · doi:10.1038/79792 · Cited by 187
Yamamoto, M., Yaginuma, K., Tsutsui, H., Sagara, J., Guan, X., Seki, E., Yasuda, K., Yamamoto, M., Akira, S., Nakanishi, K., et al. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00789.x · Cited by 183
Matikainen, S., Paananen, A., Miettinen, M., Kurimoto, M., Timonen, T. T., Julkunen, I., & Sareneva, T. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2236::aid-immu2236>3.0.co;2-g · Cited by 182
A new nomenclature for IL-1-family genes
Sims, J. E., Pan, Y., Smith, D. E., Nicklin, M. J. H., Barton, J. L., Bazan, J. F., Kastelein, R. A., Busfield, S. J., Ford, J. E., Lin, H., et al. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02040-3 · Cited by 181
IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma
Smith, D. E. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03384.x · Cited by 173
Interleukin-18 Protects Mice against Acute Herpes Simplex Virus Type 1 Infection
Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M., & Kurimoto, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2401-2409.1999 · Cited by 169
Psoriasis as a systemic disease
Grozdev, I., Korman, N., & Tsankov, N. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.11.001 · Cited by 168
Synovial Macrophages in Osteoarthritis: The Key to Understanding Pathogenesis?
Thomson, A., & Hilkens, C. M. U. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678757 · Cited by 167
Elevated serum levels of free interleukin-18 in adult-onset Still’s disease
Girard, C., Rech, J., Brown, M., Allali, D., Roux-Lombard, P., Spertini, F., Schiffrin, E. J., Schett, G., Manger, B., Bas, S., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kew300 · Cited by 166
Immunopathogenesis of inflammatory myopathies
Dalakas, M. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370709 · Cited by 163
Animal Models of Myasthenia Gravis
Christadoss, P., Poussin, M., & Deng, C. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4807 · Cited by 163
Gutcher, I., Urich, E., Wolter, K., Prinz, M., & Becher, B. (2006) · Nature Immunology · doi:10.1038/ni1377 · Cited by 161
Fantuzzi, G., & Dinarello, C. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.489 · Cited by 156
Cytokine disturbances in systemic lupus erythematosus
Jacob, N., & Stohl, W. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3349 · Cited by 151
IL-18 in inflammatory and autoimmune disease
Sedimbi, S. K., Hägglöf, T., & Karlsson, M. C. I. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1425-y · Cited by 150
Joosten, L. A. B., Radstake, T. R. D. J., Lubberts, E., van den Bersselaar, L. A. M., van Riel, P. L. C. M., van Lent, P. L. E. M., Barrera, P., & van den Berg, W. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10814 · Cited by 142
Tomura, M., Maruo, S., Mu, J., Zhou, X., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Clark, S., Kurimoto, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3759 · Cited by 140
A Critical Role for IL-18 in the Proliferation and Activation of NK1.1+CD3− Cells
Tomura, M., Zhou, X., Maruo, S., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Tanimoto, T., Kurimoto, M., & Fujiwara, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4738 · Cited by 138
Huang, W., Huang, P., & Hillert, J. A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1071oa · Cited by 138
Omoto, Y., Tokime, K., Yamanaka, K., Habe, K., Morioka, T., Kurokawa, I., Tsutsui, H., Yamanishi, K., Nakanishi, K., & Mizutani, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8315 · Cited by 137
Kalina, U., Kauschat, D., Koyama, N., Nuernberger, H., Ballas, K., Koschmieder, S., Bug, G., Hofmann, W., Hoelzer, D. F., & Ottmann, O. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1307 · Cited by 136
Kanai∥, T., Watanabe, M., Okazawa, A., Nakamaru, K., Okamoto, M., Naganuma, M., Ishii, H., Ikeda, M., Kurimoto, M., & Hibi∥, T. (2000) · Gastroenterology · doi:10.1053/gast.2000.20260 · Cited by 133
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
Mende, R., Vincent, F. B., Kandane‐Rathnayake, R., Koelmeyer, R., Lin, E. P.-Y., Chang, J., Hoi, A. Y.-B., Morand, E. F., Harris, J., & Lang, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01250 · Cited by 133
Granzyme B is a novel interleukin-18 converting enzyme
Omoto, Y., Yamanaka, K., Tokime, K., Kitano, S., Kakeda, M., Akeda, T., Kurokawa, I., Gabazza, E. C., Tsutsui, H., Katayama, N., et al. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.05.004 · Cited by 129
O'Neill, L. A. J. (2000) · Science s STKE · doi:10.1126/stke.442000re1 · Cited by 126
Development of CD8+ Effector T Cells Is Differentially Regulated by IL-18 and IL-12
Okamoto, I., Kohno, K., Tanimoto, T., Ikegami, H., & Kurimoto, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3202 · Cited by 124
Purification of a factor which provides a costimulatory signal for gamma interferon production
Nakamura, K., Okamura, H., Nagata, K., et al. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.64-70.1993 · Cited by 121
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease
Bossù, P., Neumann, D., Giudice, E. D., Ciaramella, A., Gloaguen, I., Fantuzzi, G., Dinarello, C. A., Carlo, E. D., Musiani, P., Meroni, P. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336094100 · Cited by 120
Tomura, M., Maruo, S., Mu, J., Zhou, X., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Clark, S., Kurimoto, M., et al. (1998) · PubMed · Cited by 119
Sakao, Y., Takeda, K., Tsutsui, H., Kaisho, T., Nomura, F., Okamura, H., Nakanishi, K., & Akira, S. (1999) · International Immunology · doi:10.1093/intimm/11.3.471 · Cited by 118
Association between adult-onset Still's disease and interleukin-18 gene polymorphisms
Sugiura, T., Kawaguchi, Y., Harigai, M., Terajima-Ichida, H., Kitamura, Y., Furuya, T., Ichikawa, N., Kotake, S., Tanaka, M., Hara, M., et al. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363922 · Cited by 115
Morel, J., Park, C. C., Zhu, K., Kumar, P., Ruth, J. H., & Koch, A. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206337200 · Cited by 112
Increased serum levels of interleukin-18 in patients with multiple sclerosis
Nicoletti, F., Marco, R. D., Mangano, K., Patti, F., Reggio, E., Nicoletti, A. S. Q., Bendtzen, K., & Reggio, A. (2001) · Neurology · doi:10.1212/wnl.57.2.342 · Cited by 111
IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence
Chiang, H.-Y., Lu, H.-H., Sudhakar, J. N., Chen, Y., Shih, N.-S., Weng, Y.-T., & Shui, J. (2022) · Nature Communications · doi:10.1038/s41467-022-28478-3 · Cited by 109
Kaser, A., Kaser, S., Kaneider, N. C., Enrich, B., Wiedermann, C. J., & Tilg, H. (2003) · Blood · doi:10.1182/blood-2002-07-2322 · Cited by 106
IL-18 in patients with multiple sclerosis
Losy, J., & Niezgoda, A. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00356.x · Cited by 104
Schinnerling, K., Rosas, C., Soto, L., Thomas, R., & Aguillón, J. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00203 · Cited by 101
Amin, M. A., Mansfield, P. J., Pákozdi, A., Campbell, P. L., Ahmed, S., Martinez, R. J., & Koch, A. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22705 · Cited by 96
Expression of IL-18 in psoriasis
Ohta, Y., Hamada, Y., & Katsuoka, K. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100240 · Cited by 95
IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
Williams, M. A., O’Callaghan, A. A., & Corr, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01091 · Cited by 95
Ohkusu, K., Yoshimoto, T., Takeda, K., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2449-2456.2000 · Cited by 94
Design of humanized antibodies: From anti-Tac to Zenapax
Tsurushita, N., Hinton, P. R., & Kumar, S. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.007 · Cited by 92
Wyman, T. H., Dinarello, C. A., Banerjee, A. M., Gamboni-Robertson, F., Hiester, A. A., England, K. M., Kelher, M. R., & Silliman, C. C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.401 · Cited by 89
Rothe, H., Hausmann, A., Casteels, K., Okamura, H., Kurimoto, M., Burkart, V., Mathieu, C., & Kolb, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1230 · Cited by 85
Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice
Oikawa, Y., Shimada, A., Kasuga, A., Morimoto, J., Osaki, T., Tahara, H., Miyazaki, T., Tashiro, F., Yamato, E., Miyazaki, J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5865 · Cited by 84
Morel, J., Park, C. C., Kumar, P., & Koch, A. E. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780351 · Cited by 84
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity
Colafrancesco, S., Priori, R., Alessandri, C., Perricone, C., Pendolino, M., Picarelli, G., & Valesini, G. (2012) · International Journal of Inflammation · doi:10.1155/2012/156890 · Cited by 81
McKie, E., Reid, J. L., Mistry, P. C., DeWall, S. L., Abberley, L., Ambery, P., & Extremera, B. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150018 · Cited by 80
Koper‐Lenkiewicz, O. M., Sutkowska, K., Wawrusiewicz‐Kurylonek, N., Kowalewska, E., & Matowicka-Karna, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042106 · Cited by 79
Telomere dysfunction activates YAP1 to drive tissue inflammation
Chakravarti, D., Hu, B., Mao, X., Rashid, A., Li, J., Li, J., Liao, W.-T., Whitley, E. M., Dey, P., Hou, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18420-w · Cited by 77
Nakahira, M., Tomura, M., 岩崎, 正., Ahn, H., Bian, Y., Hamaoka, T., Ohta, T., Kurimoto, M., & Fujiwara, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1306 · Cited by 76
Cytokine-Mediated Activation of NK Cells during Viral Infection
Freeman, B. E., Raué, H.-P., Hill, A. B., & Slifka, M. K. (2015) · Journal of Virology · doi:10.1128/jvi.00199-15 · Cited by 75
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus
Italiani, P., Manca, M. L., Angelotti, F., Melillo, D., Pratesi, F., Puxeddu, I., Boraschi, D., & Migliorini, P. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1525-z · Cited by 75
Gangemi, S., Merendino, R. A., Guarneri, F., Minciullo, P., DiLorenzo, G., Pacor, M. L., & Cannavò, S. (2003) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2003.00647.x · Cited by 74
Pathogenesis of Type 1 Diabetes: Implications for Incidence Trends
Knip, M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000329169 · Cited by 71
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 71
Ishikura, T., Kanai∥, T., Uraushihara, K., Iiyama, R., Makita, S., Totsuka, T., Yamazaki, M., Sawada, T., Nakamura, T., Miyata, T., et al. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03097.x · Cited by 70
Vandenhaute, J., Wouters, C. H., & Matthys, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03089 · Cited by 70
Thomas, J., Huuskes, B. M., Sobey, C. G., Drummond, G. R., & Vinh, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108191 · Cited by 67
Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies
Mavragani, C. P., Spyridakis, E., & Koutsilieris, M. (2012) · International Journal of Inflammation · doi:10.1155/2012/879020 · Cited by 66
Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis
Priori, R., Barone, F., Alessandri, C., Colafrancesco, S., McInnes, I. B., Pitzalis, C., Valesini, G., & Bombardieri, M. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq397 · Cited by 64
Bank, S., Andersen, P. S., Burisch, J. M., Pedersen, N. K., Roug, S., Galsgaard, J., Turino, S. Y., Brodersen, J. B., Rashid, S., Rasmussen, B. K., et al. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.84 · Cited by 64
Liu, C.-L., Ren, J., Wang, Y., Zhang, X., Sukhova, G. K., Liao, M., Santos, M. M., Luo, S., Yang, D., Xia, M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz856 · Cited by 64
Gono, T., Kawaguchi, Y., Sugiura, T., Ichida, H., Takagi, K., Katsumata, Y., Hanaoka, M., Okamoto, Y., Ota, Y., & Yamanaka, H. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq196 · Cited by 63
Cell-cell interactions in synovitis. Endothelial cells and immune cell migration.
Szekanecz, Z., & Koch, A. E. (2000) · Arthritis Research · doi:10.1186/ar114 · Cited by 63
BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation
Deason, K. L., Troutman, T. D., Jain, A., Challa, D. K., Mandraju, R., Brewer, T., Ward, E. S., & Pasare, C. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171810 · Cited by 63
Imamura, M., Tsutsui, H., Yasuda, K., Uchiyama, R., Futatsugi‐Yumikura, S., Mitani, K., Hayashi, S., Akira, S., Taniguchi, S., van Rooijen, N., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.027 · Cited by 62
Yoshimoto, T., Nagai, N., Ohkusu, K., Ueda, H., Okamura, H., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1483 · Cited by 61
Impellizzeri, D., Siracusa, R., Cordaro, M., Peritore, A. F., Gugliandolo, E., Mancuso, G., Midiri, A., Paola, R. D., & Cuzzocrea, S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.029 · Cited by 60
Leach, S. T., Messina, I., Lemberg, D. A., Novick, D., Rubenstein, M., & Day, A. S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20272 · Cited by 59
Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances
Sfriso, P., Bindoli, S., & Galozzi, P. (2018) · Drugs · doi:10.1007/s40265-018-0956-9 · Cited by 58
Im, S., Barchan, D., Maiti, P. K., Raveh, L., Souroujon, M. C., & Fuchs, S. (2001) · The FASEB Journal · doi:10.1096/fj.01-0072com · Cited by 57
Satoh, Y., Esche, C., Gambotto, A. A., et al. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01050.x · Cited by 57
Increased expression of IL-18 in the serum and islets of type 1 diabetics
Harms, R. Z., Yarde, D. N., Guinn, Z. P., Lorenzo-Arteaga, K. M., Corley, K. P., Cabrera, M. S., & Sarvetnick, N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.012 · Cited by 56
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells
Alboni, S., Montanari, C., Benatti, C., Sánchez-Alavez, M., Rigillo, G., Blom, J. M. C., Brunello, N., Conti, B., Pariante, C. M., & Tascedda, F. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.015 · Cited by 56
Telomere dysfunction instigates inflammation in inflammatory bowel disease
Chakravarti, D., Lee, R., Multani, A. S., Santoni, A., Keith, Z., Hsu, W., Chang, K., Reyes-Uribe, L., Rashid, A., Wu, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024853118 · Cited by 56
Lewis, E. C., & Dinarello, C. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607917103 · Cited by 53
Yoshimoto, T., Nagai, N., Ohkusu, K., et al. (1998) · PubMed · Cited by 53
Tsoi, L. C., Gharaee‐Kermani, M., Berthier, C. C., Nault, T., Hile, G. A., Estadt, S. N., Patrick, M. T., Wasikowski, R., Billi, A. C., Lowe, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.139558 · Cited by 52
Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases
Harel, M., Fauteux‐Daniel, S., Girard-Guyonvarc'h, C., & Gabay, C. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155781 · Cited by 52
Rothe, H., Hibino, T., Itoh, Y., et al. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0135 · Cited by 51
Alagkiozidis, I., Facciabene, A., Carpenito, C., Benencia, F., Jonak, Z., Adams, S. F., Carroll, R. G., Gimotty, P. A., Hammond, R., Danet-Desnoyers, G., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-104 · Cited by 50
Kabakchieva, P., Gateva, A., Velikova, T. V., Georgiev, T., Yamanishi, K., Okamura, H., & Kamenov, Z. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000442 · Cited by 46
Interleukin-18 directly protects cortical neurons by activating PI3K/AKT/NF-κB/CREB pathways
Zhou, J., Ping, F., Lv, W.-T., Feng, J.-Y., & Shang, J. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.003 · Cited by 45
Mokry, L. E., Zhou, S., Guo, C., Scott, R. A., Devey, L. R., Langenberg, C., Wareham, N. J., Waterworth, D. M., Cardon, L. R., Sanséau, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45747-2 · Cited by 45
El‐Darawish, Y., Li, W., Yamanishi, K., Pencheva-Demireva, M., Oka, N., Yamanishi, H., Matsuyama, T., Tanaka, Y., Minato, N., & Okamura, H. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1hi1017-396rr · Cited by 44
Kobayashi, K., Nakata, N., Kai, M., Kasama, T., Hanyuda, Y., & Hatano, Y. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4421 · Cited by 42
Cho, D., Kang, J. S., Park, J. H., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02433-6 · Cited by 40
Chandrasekar, B., Patel, D. N., Mummidi, S., Kim, J. W., Clark, R. A., & Valente, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708142200 · Cited by 40
Rackov, G., Zaniani, P. T., Colomo, S., Shokri, R., Monserrat, J., Álvarez‐Mon, M., Martínez‐A, C., & Balomenos, D. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04907-5 · Cited by 40
Boyle, A. J., Ferris, P., Bradbury, I., Conlon, J., Shankar‐Hari, M., Rogers, A. J., O’Kane, C. M., & McAuley, D. F. (2022) · Critical Care · doi:10.1186/s13054-022-04025-w · Cited by 40
Eitan, C., Siany, A., Barkan, E., Olender, T., van Eijk, K. R., Moisse, M., Farhan, S. M. K., Danino, Y. M., Yanowski, E., Marmor-Kollet, H., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01040-6 · Cited by 38
Wu, C., Yang, H., Yao, T., Liu, S., & Huang, J. (2016) · Medicine · doi:10.1097/md.0000000000005037 · Cited by 38
IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice
Li, X., Cui, W., Hull, L., Wang, L., Yu, T., & Xiao, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-75675-5 · Cited by 38
Serum Interleukin-18 Concentrations in Patients With Inflammatory Bowel Disease
Furuya, D., Yagihashi, A., Komatsu, M., Nakamura, M., Tsuji, N., Kobayashi, D., & Watanabe, N. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203001-00010 · Cited by 35
D’Angelo, C., Reale, M., Costantini, E., Nicola, M. D., Porfilio, I., de Andrés, C., Fernández-Paredes, L., Sánchez‐Ramón, S., & Pasquali, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01240 · Cited by 35
Zhao, G., Zhang, H., Zhu, S., Wang, S., Zhu, K., Zhao, Y., Xu, L., Zhang, P., Xie, J., Sun, A., et al. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110141 · Cited by 35
Niu, X., Huang, Y., Gao, Y., Sun, Y., Yang, H., Chen, H., Gao, X., & Qi, R. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000140 · Cited by 34
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis
Pourani, M. R., Abdollahimajd, F., Zargari, O., & Shahidi‐Dadras, M. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1966357 · Cited by 33
The role of Interleukin-18 in recurrent early pregnancy loss
Löb, S., Ochmann, B., Ma, Z., Vilsmaier, T., Kühn, C., Schmoeckel, E., Herbert, S.-L., Kolben, T., Wöckel, A., Mahner, S., et al. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103432 · Cited by 33
Detry, S., Andries, J., Bloch, Y., Gabay, C., Clancy, D. M., & Savvides, S. N. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101908 · Cited by 33
Vasilev, G., Manolova, I., Ivanova, M. G., Stanilov, I., Miteva, L. D., & Stanilova, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-94841-x · Cited by 31
Girard-Guyonvarc’h, C., Harel, M., & Gabay, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020430 · Cited by 30
Pralnacasan (vertex pharmaceuticals).
Siegmund, B., & Zeitz, M. (2003) · PubMed · Cited by 28
Kawa, K., Tsutsui, H., Uchiyama, R., Kato, J., Matsui, K., Iwakura, Y., Matsumoto, T., & Nakanishi, K. (2010) · International Immunology · doi:10.1093/intimm/dxp122 · Cited by 28
Immunotherapeutic Applications of IL-18
Tsutsui, H., & Nakanishi, K. (2012) · Immunotherapy · doi:10.2217/imt.12.137 · Cited by 28
Pietrzak, D., Pietrzak, A., Grywalska, E., Kiciński, P., Roliński, J., Donica, H., Franciszkiewicz-Pietrzak, K., Borzęcki, A., Socha, M., Niedziałek, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201589 · Cited by 28
A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling
Li, S., Jiang, L., Beckmann, K., Højen, J. F., Pessara, U., Powers, N. E., de Graaf, D. M., Azam, T., Lindenberger, J. J., Eisenmesser, E. Z., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100630 · Cited by 27
Interleukin‐18 prevents apoptosis via PI3K/Akt pathway in normal human keratinocytes
Hosotani, Y., Kashiwamura, S., Kimura-Shimmyo, A., Sekiyama, A., Ueda, H., Ikeda, T., Mimura, O., & Okamura, H. (2008) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2008.00513.x · Cited by 26
Helmers, S. B., Bruton, M., Loell, I., Ulfgren, A., Gracie, A., McInnes, I. B., & Lundberg, I. E. (2018) · Lara D. Veeken · doi:10.1093/rheumatology/key222 · Cited by 24
IL-18 is required for self-reactive T cell expansion in NOD mice
Marleau, A. M., & Sarvetnick, N. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.005 · Cited by 22
Nariai, Y., Kamino, H., OBAYASHI, E., Kato, H., Sakashita, G., Sugiura, T., Migita, K., Koga, T., Kawakami, A., Sakamoto, K., et al. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.001 · Cited by 22
Su, Y., & Zhao, H. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000509110 · Cited by 22
Zhang, X., Luo, S., Wang, M., Huang, Q. M., Fang, W., Li, J., Liu, T., Zhang, Y., Deng, Z., Liu, C.-L., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.013 · Cited by 22
Dong, G., Liang, L., Fu, J., & Zou, C. (2007) · PubMed · Cited by 20
An innate interaction between IL-18 and the propeptide that inactivates its precursor form
Tsutsumi, N., Ayumi, Y., Kimura, T., Kato, Z., Fukao, T., Shirakawa, M., Ohnishi, H., & Tochio, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-42661-5 · Cited by 20
Liang, R., Zheng, L., Ji, T., Zheng, J., Liu, J., Yuan, C., Huang, Q., & Yang, M. (2022) · Lupus · doi:10.1177/09612033211069853 · Cited by 20
MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis
Wu, N., Chen, D., Sun, H., Tan, J., Zhang, Y., Zhang, T., Han, Y., Liu, H., Ouyang, X., Yang, X., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1720-9 · Cited by 19
Mierzejewska, J., Węgierek‐Ciura, K., Rossowska, J., Szczygieł, A., Anger, N., Szermer-Olearnik, B., Geneja, M., & Pajtasz‐Piasecka, E. (2022) · Journal of Immunology Research · doi:10.1155/2022/7508928 · Cited by 19
Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries
Qu, H., Snyder, J., Connolly, J., Glessner, J., Kao, C., Abou‐Sleiman, P. M., & Hakonarson, H. H. (2022) · Biomedicines · doi:10.3390/biomedicines10020264 · Cited by 17
Interleukin‐18 mediated inflammatory brain injury after intracerebral hemorrhage in male mice
Li, H., Tian, J., Yin, Y., Diao, S., Zhang, X., Zuo, T., Miao, Z., & Yang, Y. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25044 · Cited by 16
Interleukin-18 signaling system links to agitation in severe mental disorders
Hjell, G., Szabó, A., Mørch-Johnsen, L. E., Holst, R., Tesli, N., Bell, C., Fischer-Vieler, T., Werner, M. C. F., Lunding, S. H., Ormerod, M. B. E. G., et al. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105721 · Cited by 14
Inflammasomes and Type 1 Diabetes
Pearson, J. A., Wong, F. S., & Li, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686956 · Cited by 13
Ohya, T., Nishimura, K., Murase, A., Hattori, S., Ohara, A., Nozawa, T., Hara, R., & Ito, S. (2022) · ACR Open Rheumatology · doi:10.1002/acr2.11426 · Cited by 13
Cheng, L., Dong, R., Song, C., Li, X., Zhang, L., Shi, M., Lv, C., Wang, L., Kou, J., Xie, H., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.836311 · Cited by 12
Cited by
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Al-Qahtani, A. A., Alhamlan, F. S., & Al-Qahtani, A. A. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010013 · Cited by 291
Metadata
- Authors
- Ihim, S. A., Abubakar, S. D., Zian, Z., Sasaki, T., Saffarioun, M., Maleknia, S., & Azizi, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-08-11
- Volume
- 13
- Pages
- 919973-919973
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4291018370
- Cited by
- 378
- References
- 207
- FWCI
- 26.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.